Jack Nathan Medical Corp. (JNH.V)
CAD 0.03
(0.0%)
CAD 0.03
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -6.1 Million | -2 Million | -809.15 Thousand | -66.53 Thousand | -66.53 Thousand | -33.68 Thousand |
| Net Income | -6.63 Million | -6.9 Million | -9.91 Million | -134.61 Thousand | -134.61 Thousand | -18.08 Thousand |
| Depreciation & Amortization | 1.22 Million | 1.07 Million | 144.83 Thousand | 144.83 Thousand | - | - |
| Deferred income taxes | - | 1.4 Million | 486.09 Thousand | -8.54 Million | - | - |
| Stock-based compensation | 648.59 Thousand | 1.12 Million | 2.49 Million | 839.02 Thousand | 58.9 Thousand | - |
| Change in working capital | -1.61 Million | 1.37 Million | -762.97 Thousand | 9184.00 | 9184.00 | -15.6 Thousand |
| Other non-cash items | 266.3 Thousand | -83.7 Thousand | 8.39 Million | 8.39 Million | 58.9 Thousand | - |
| Investing Cash Flow | -4.08 Million | -2.68 Million | -252.89 Thousand | -252.89 Thousand | - | - |
| Investments in PPE | -4.08 Million | -2.58 Million | -499.74 Thousand | -499.74 Thousand | - | - |
| Acquisitions | - | -174.3 Thousand | 246.84 Thousand | 246.84 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.87 Million | 74.4 Thousand | - | - | - | - |
| Financing Cash Flow | 11.91 Million | 5.27 Million | 8.67 Million | 389.1 Thousand | 389.1 Thousand | 50 Thousand |
| Debt repayment | -10.38 Million | -592.85 Thousand | -419.01 Thousand | -419.01 Thousand | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | 3.67 Million | 4.72 Million | 487.6 Thousand | 487.6 Thousand | 50 Thousand |
| Other Financing Activities | 1.52 Million | 2.19 Million | 4.37 Million | 320.51 Thousand | -98.49 Thousand | - |
| Accounts receivables | -1.67 Million | 3629.00 | -92.73 Thousand | -92.73 Thousand | - | - |
| Accounts payables | 840.27 Thousand | - | 244.02 Thousand | 244.02 Thousand | - | - |
| Inventory | - | - | -883.74 Thousand | -111.59 Thousand | - | - |
| Other working capital | 62.5 Thousand | 1.37 Million | -30.52 Thousand | -30.52 Thousand | 9184.00 | - |
| Cash at beginning of period | 1.46 Million | 1.06 Million | 7.68 Million | 84.2 Thousand | 84.2 Thousand | 67.88 Thousand |
| Cash at end of period | 3.06 Million | 1.46 Million | 7.68 Million | 406.77 Thousand | 406.77 Thousand | 84.2 Thousand |
| Capital Expenditure | -4.08 Million | -2.58 Million | -499.74 Thousand | -499.74 Thousand | - | - |
| Effect of forex changes on cash | -109.15 Thousand | -188.82 Thousand | 72.01 Thousand | 72.01 Thousand | - | - |
| Net cash flow / Change in cash | 1.6 Million | 397.64 Thousand | - | 322.57 Thousand | 322.57 Thousand | 16.31 Thousand |
| Free Cash Flow | -10.19 Million | -4.59 Million | -1.3 Million | -566.27 Thousand | -66.53 Thousand | -33.68 Thousand |
| Breakdown | 2024 FY | 2024 Q4 | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -6.63 Million | -2.25 Million | -819.18 Thousand | -1.39 Million | -789.89 Thousand | -6.9 Million |
| Depreciation & Amortization | 1.17 Million | 306.01 Thousand | 263.87 Thousand | 258.95 Thousand | 296.34 Thousand | 1.07 Million |
| Deferred income taxes | - | - | - | - | - | 1.4 Million |
| Stock-based compensation | - | - | 115.31 Thousand | 166.22 Thousand | 188.86 Thousand | 1.12 Million |
| Change in working capital | -662.21 Thousand | -1.43 Million | 202.51 Thousand | 734.02 Thousand | -55.34 Thousand | 1.37 Million |
| Other non-cash items | 3.17 Million | 2.15 Million | 27.04 Thousand | 47.38 Thousand | 57.76 Thousand | -83.7 Thousand |
| Investing Cash Flow | -4.08 Million | -1.45 Million | -650.63 Thousand | -170.36 Thousand | -616.01 Thousand | -2.68 Million |
| Investments in PPE | -217.63 Thousand | 2.41 Million | -650.63 Thousand | -170.36 Thousand | -616.01 Thousand | -2.58 Million |
| Acquisitions | - | - | - | - | - | -174.3 Thousand |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -3.87 Million | -3.87 Million | - | 592.06 Thousand | -592.06 Thousand | 74.4 Thousand |
| Financing Cash Flow | 11.91 Million | 2.42 Million | 1.91 Million | 353.5 Thousand | 651.52 Thousand | 5.27 Million |
| Debt repayment | -10.76 Million | -1.79 Million | -161.74 Thousand | -193.99 Thousand | -102.15 Thousand | -592.85 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | -412.5 Thousand | 412.5 Thousand | 3.67 Million |
| Other Financing Activities | 1.52 Million | 788.43 Thousand | 2.07 Million | 960 Thousand | 341.18 Thousand | 2.19 Million |
| Accounts receivables | -1.64 Million | -1.3 Million | -102.48 Thousand | 77.83 Thousand | 222.16 Thousand | 3629.00 |
| Accounts payables | 840.27 Thousand | -46.97 Thousand | 1.31 Million | - | - | - |
| Inventory | - | - | -1.31 Million | - | - | - |
| Other working capital | 140.9 Thousand | -88.22 Thousand | 304.99 Thousand | 656.18 Thousand | -277.5 Thousand | 1.37 Million |
| Cash at beginning of period | 1.46 Million | 5.28 Million | 816.48 Thousand | 794.82 Thousand | 1.46 Million | 1.06 Million |
| Cash at end of period | 3.06 Million | 3.06 Million | 1.6 Million | 816.48 Thousand | 1.13 Million | 1.46 Million |
| Capital Expenditure | -217.63 Thousand | 2.41 Million | -650.63 Thousand | -170.36 Thousand | -616.01 Thousand | -2.58 Million |
| Effect of forex changes on cash | - | - | -338.32 Thousand | 22.38 Thousand | -64.19 Thousand | -188.82 Thousand |
| Net cash flow / Change in cash | 1.6 Million | -2.22 Million | 787.36 Thousand | 21.66 Thousand | -330.94 Thousand | 397.64 Thousand |
| Free Cash Flow | -6.32 Million | -775.34 Thousand | -786.5 Thousand | -354.21 Thousand | -918.28 Thousand | -4.59 Million |
CNFR
VINDHYATEL
EDVGF
JNDOF
ZEUS
MDNE3